More New Drug Research

Mozambique begins recruiting participants for ANTICOV clinical trial to test early treatments for COVID-19

The two centers in Mozambique with which ISGlobal is working for the large ANTICOV clinical trial have begun recruiting participants following in the footsteps of the Democratic Republic of Congo (DRC), Ghana, Guinea, Kenya and Mali. The goal of the trial, which is being conducted in 13 African countries, is to find an effective treatment that prevents worsening in patients with mild to moderate COVID-19 symptoms.